Upper Respiratory Illness Vaccines

Article1 October 1962Upper Respiratory Illness VaccinesPerspectives and TrialsWILLIAM J. MOGABGAB, M.D., F.A.C.P.WILLIAM J. MOGABGAB, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-57-4-526 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe story of immunization for prevention of upper respiratory illnesses began during the second World War with influenza virus vaccines (1). Additions to the antigenic components and refinements in preparation and inactivation of the viruses derived from growth in the allantoic sac of the embryonated egg followed. Except for the prophylactic application of antibiotics for streptococcal pharyngitis little was added to the measures used for prevention of upper respiratory illnesses prior to isolation of the adenoviruses and development of vaccines from viruses propagated in tissue culture (2). Only types 3, 4, and 7 have been included because these adenoviruses have...References1. FRANCIS T: Influenza, in Viral and Rickettsial Infections in Man, 3rd Ed., ed. by Rivers, T., and Horsfall, F. L., Jr., J. B. Lippincott, Philadelphia, 1959, p. 633. CrossrefGoogle Scholar2. DINGLEGINSBERG JHHS: The adenovirus group, in Viral and Rickettsial Infections in Man, 3rd Ed., ed. by Rivers, T., and Horsfall, F. L., Jr., J. B. Lippincott, Philadelphia, 1959, p. 613. Google Scholar3. HUEBNERBELLROWE RJJAW: The importance of adenoviruses as agents of respiratory and ocular illnesses, in Cellular Biology, Nucleic Acids and Viruses, ed. by St. Whitelock, O., Ann. N. Y. Acad. Sci. 5: 393, 1957. Google Scholar4. DAVENPORTHENNESSYBELL FMAVJA: Immunologic advantages of emulsified influenza virus vaccines. Milit. Med. 127: 95, 1962. CrossrefMedlineGoogle Scholar5. MEIKLEJOHN G: Adjuvant influenza adenovirus vaccine. JAMA 179: 594, 1962. CrossrefMedlineGoogle Scholar6. MOGABGAB WJ: Annual influenza vaccination as a lifesaving measure. Amer. Heart J. 62: 587, 1961. CrossrefGoogle Scholar7. MOGABGAB WJ: in Abstracts, Eighth International Congress of Microbiology, ed. by Passinet, M., Montreal, 1962. Google Scholar8. MOGABGAB WJ: Recent developments in upper respiratory disease. Amer. J. Med. Sci. 237: 115, 1959. CrossrefMedlineGoogle Scholar9. WEAVERMOGABGABHOLPER NKWJJ: The prevention of acute upper respiratory diseases. To be published. Google Scholar10. DICKMOGABGABHOLMES ECWJB: Characteristics of para-influenza 1 (HA-2) virus. I. Incidence of infection and clinical features in adults. Amer. J. Hyg. 73: 263, 1961. MedlineGoogle Scholar11. DICKMOGABGAB ECWJ: Characteristics of parainfluenza 1 (HA-2) virus. II. Hemagglutination, hemagglutination-inhibition and neutralization. Amer. J. Hyg. 73: 273, 1961. MedlineGoogle Scholar12. DICKMOGABGAB ECWJ: Characteristics of parainfluenza 1 (HA-2) virus. III. Antigenic relationships, growth, interaction with erythrocytes, and physical properties. J. Bact. 83: 661, 1962. Google Scholar13. MOGABGABDICKHOLMES WJECB: Parainfluenza 2 (CA) virus in young adults. Amer. J. Hyg. 74: 304, 1961. MedlineGoogle Scholar14. MOGABGAB WJ: 2060 Virus (ECHO 28) in KB cell cultures, characteristics, complement-fixation and antigenic relationships to some other respiroviruses. Amer. J. Hyg. 76: 15, 1962. MedlineGoogle Scholar15. MOGABGAB WJ: Additional respirovirus type related to GL 2060 (ECHO 28) virus from military personnel, 1959. Amer. J. Hyg. 76: 160, 1962. MedlineGoogle Scholar16. CHANOCKJOHNSON RMKM: Infectious disease: respiratory viruses. Ann. Rev. Med. 12: 1, 1961. CrossrefMedlineGoogle Scholar17. HILLEMANHAMPARIANKETLERREILLYMCCLELLANDCORNFELDSTOKES MRVVACMLDJ: Acute respiratory illnesses among children and adults, field study of contemporary importance of several viruses and appraisal of the literature. JAMA 180: 445, 1962. CrossrefMedlineGoogle Scholar18. TAYLOR-ROBINSONTYRRELL DDA: Serotypes of viruses (rhinoviruses) isolated from common cold. Lancet 1: 452, 1962. CrossrefMedlineGoogle Scholar19. MOGABGAB WJ: Influenza C virus in monkey kidney tissue cultures. J. Bact. 83: 209, 1962. CrossrefMedlineGoogle Scholar20. HAMREPROCKNOW DJJ: Viruses isolated from natural common colds in the U. S. A. Brit. Med. J. 2: 1382, 1961. CrossrefMedlineGoogle Scholar21. LENNETTEFOXSCHMIDTCULVER EHVHNJJO: The Coe virus: an apparently new virus recovered from patients with mild respiratory disease. Amer. J. Hyg. 68: 272, 1958. MedlineGoogle Scholar22. HENLEHENLEHUMMELERLIEF WGKFS: The changing aspects of the serodiagnosis of viral infection. J. Pediat. 59: 827, 1961. CrossrefMedlineGoogle Scholar23. CHANOCKWONGHUEBNERBELL RMDCRJJA: Serological response of individuals infected with para-influenza virus. Amer. J. Public Health 50: 1858, 1960. CrossrefGoogle Scholar24. SIMPSONMOGABGAB GIWJ: Reactivity of influenza A and B viruses propagated in cultures of human embryo tissues and in the chick embryo. J. Immun. 78: 456, 1957. MedlineGoogle Scholar25. MOGABGAB WJ: Influenza A and B viruses in monkey kidney cultures. II. Immunogenicity and characteristics of the neutralization reaction as compared to those of chick embryo propagated viruses. J. Infect. Dis. 109: 136, 1961. CrossrefMedlineGoogle Scholar26. HAYFLICKMOORHEAD LPS: The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585, 1961. CrossrefMedlineGoogle Scholar27. CHANOCKBELLPARROTT RMJARH: Natural history of para-influenza infection, in Perspectives in Virology, Vol. II, ed. by Pollard, M., Burgess Publishing Company, Minneapolis, 1961, chap. 11, p. 126. Google Scholar28. MAASSAB HF: The propagation of multiple viruses in chick kidney cultures. Proc. Nat. Acad. Sci. U. S. A. 45: 1035, 1959. CrossrefMedlineGoogle Scholar29. SWEETHILLEMAN BHMR: The vacuolating virus SV 40. Proc. Soc. Exp. Biol. Med. 105: 420, 1960. CrossrefMedlineGoogle Scholar30. EDDYBORMANGRUBBSYOUNG BEGSGERD: Identification of the oncogenic substance in Rhesus monkey kidney cell cultures as Simian Virus 40. Virology 17: 65, 1962. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New Orleans, LouisianaFrom the Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana.This investigation was supported in part by United States Public Health Service grant no. E 1131; Abbott Laboratories, North Chicago, Illinois; and the National Drug Company, Philadelphia, Pennsylvania.Requests for reprints should be addressed to William J. Mogabgab, M.D., Department of Medicine, Division of Infectious Disease, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans 12, Louisiana. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByRhinovirusesRhinovirusesRhinovirusesRhinovirusesRhinovirusesFunktionell-synergistische Kombinationsvaccinen Ein neuer ImpfstofftypRhinovirusesRhinovirusesPresent Knowledge of the Rhinovirus Group of VirusesThe Common Cold Past, Present and Future ResearchImmunologic, chemotherapeutic and interferon approaches to control of viral diseaseRS-VirusA Virologic Study of Chronic BronchitisViruses Associated with Upper Respiratory Illnesses in AdultsWILLIAM J. MOGABGAB, M.D., F.A.C.P.The Status of Immunization in 1963 1 October 1962Volume 57, Issue 4Page: 526-537KeywordsAntibioticsAntigensDrugsMedical servicesOilsPulmonary diseasesResearch laboratoriesStreptococcal pharyngitisTissue culturesVaccines Issue Published: 1 October 1962 PDF DownloadLoading ...